Hydrogels comprising cell adhesive peptides and methods of use thereof
US-2024376438-A1 · Nov 14, 2024 · US
US9283303B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9283303-B2 |
| Application number | US-201213486479-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 1, 2012 |
| Priority date | Jun 3, 2011 |
| Publication date | Mar 15, 2016 |
| Grant date | Mar 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A surgical implant comprising: a substrate having an exterior surface and a plurality of layers disposed over the substrate exterior surface. The substrate comprises a polymeric material, and the plurality of layers comprises: an activated substrate surface layer; a valve metal layer; and a porous valve metal oxide layer, wherein the valve metal layer is disposed between the activated substrate layer and the porous valve metal oxide layer. The disclosure provides for a method for producing a polymeric surgical implant. The exterior substrate surface is treated by one or more processes comprising: plasma activation; electron beam irradiation; ultraviolet light; and low energy Ar+ ion beam irradiation; producing an activated substrate surface layer. A plurality of layers is applied over the activated substrate surface layer. The surface is converted by a spark-anodization process in an alkaline bath containing Ca and P ions into a layer of porous valve metal oxide.
Opening claim text (preview).
We claim: 1. A surgical implant comprising: a substrate having an exterior surface and a plurality of layers disposed over the substrate exterior surface, wherein the substrate comprises a polymeric material, and wherein the plurality of layers comprises: (i) an activated substrate surface layer; (ii) a valve metal layer; (iii) a porous valve metal oxide layer, wherein the valve metal layer is disposed between the activated substrate layer and the porous valve metal oxide layer and a buffer layer, said buffer layer disposed between the activated substrate surface layer and the valve metal layer. 2. The surgical implant of claim 1 , wherein the polymeric material of the substrate is a thermopolymeric material. 3. The surgical implant of claim 1 , wherein the polymeric material is a polyaryletherketone (PAEK) material. 4. The surgical implant according to claim 3 , wherein the polyaryletherketone (PAEK) is independently selected from a group consisting of polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyetheretherketoneketone (PEEKK) and polyetherketoneetherketoneketone (PEKEKK). 5. The surgical implant according to claim 1 , wherein the valve metal layer is formed from a metal independently selected from the group consisting of titanium, tungsten, aluminum, hafnium, niobium, tantalum and zirconium. 6. The surgical implant according to claim 5 , wherein said porous valve metal oxide layer includes an amorphous calcium phosphate composition. 7. The surgical implant according to claim 1 , wherein the buffer layer comprises a plurality of alternating layers of a first material and a second material. 8. The surgical implant according to claim 7 , wherein the first material comprises a metal material and the second material comprises a nitride and/or a carbide of the metal material. 9. The surgical implant according to claim 8 , wherein the first material comprises Ti and Cr and the second material comprises a combination independently selected from the group consisting of TiN, CrN, TiC, CrC and mixtures thereof. 10. The surgical implant according to claim 1 , wherein each alternating layer has a thickness ranging from 10 nm to 100 nm. 11. The surgical implant according to claim 1 , wherein the buffer layer comprises a crystalline or amorphous material. 12. The surgical implant according to claim 11 , wherein the crystalline or amorphous material is independently selected from the group consisting of TiO 2 , Ta 2 O 5 , Nb 2 O 5 , ZrO 2 , SiO 2 , RuO 2 , or MoO 2 , MoO 3 , VO, VO 2 , V 2 O 3 , V 2 O 5 , CrO 2 O 3 , CrO 3 and combinations thereof. 13. The surgical implant according to claim 1 , wherein the buffer layer comprises a plurality of alternating layers of a first material, a second material and a third material. 14. The surgical implant according to claim 13 , wherein the first material is Ta 2 O 5 , the second material is AlN and the third material is Au. 15. The surgical implant according to claim 1 , wherein the buffer layer has a thickness ranging from 100 nm to 1000 nm. 16. The surgical implant according to claim 1 , wherein the substrate comprises a reinforced polyaryletherketone (PAEK). 17. The surgical implant according to claim 1 , wherein the plurality of layers substantially covers the substrate exterior surface. 18. The surgical implant according to claim 1 , wherein the porous valve metal oxide layer is coated with a silver salt layer. 19. The surgical implant according to claim 1 , wherein the substrate comprises a radiopaque material independently selected from the group consisting of Zr, ZrO 2 , ZnO, Ba, BaSO 4 , Ta, Ta 2 O 5 , Au, Nb, Nb 2 O 5 , Bi, Bi 2 O 3 and combinations thereof. 20. The surgical implant according to claim 1 , wherein the plurality of layers further comprises a polysilane layer disposed between the activated substrate surface layer and the valve metal layer. 21. The surgical implant according to claim 1 , wherein said plurality of layers further comprises a conductive layer formed from a conductive, non-oxidizable metal. 22. The surgical implant according to claim 21 , wherein the conductive, non-oxidizable metal is independently selected from the group consisting of Au, Pt, Pd and combinations thereof. 23. The surgical implant according to claim 22 , wherein the conductive layer has a thickness ranging from 100 nm to 1000 nm. 24. The surgical implant according to claim 1 , having a shape independently selected from the group consisting of: screw, pin, rods plates nails bone anchors cable ties plate with pyramids or spikes or keels, anatomical 3D plate, complex bone replacement structure, and scaffold. 25. The surgical implant according to claim 1 , wherein the porous valve metal oxide layer has pores with sizes ranging from about 0.1 μm to about 10 μm; and a pore density ranging from: about 10,000 pores/mm2 to about 500,000 pores/mm2. 26. A surgical implant comprising: a substrate having an exterior surface and a plurality of layers disposed over the substrate exterior surface, wherein the substrate comprises a polymeric material, and wherein the plurality of layers comprises: (i) an activated substrate surface layer; (ii) a valve metal layer; (iii) a porous valve metal oxide layer, wherein the valve metal layer is disposed between the activated substrate layer and the porous valve metal oxide layer; and wherein the porous valve metal oxide layer is coated with a silver salt layer. 27. The surgical implant of claim 26 , wherein the polymeric material of the substrate is a thermopolymeric material. 28. The surgical implant of claim 26 , wherein the polymeric material is a polyaryletherketone (PAEK) material. 29. The surgical implant according to claim 28 , wherein the polyaryletherketone (PAEK) is independently selected from a group consisting of polyetherketone (PEK), polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyetheretherketoneketone (PEEKK) and polyetherketoneetherketoneketone (PEKEKK). 30. The surgical implant according to claim 26 , wherein the valve metal layer is formed from a metal independently selected from the group consisting of titanium, tungsten, aluminum, hafnium, niobium, tantalum and zirconium. 31. The surgical implant according to claim 30 , wherein said porous valve metal oxide layer includes an amorphous calcium phosphate composition. 32. The surgical implant according to claim 26 , further comprising a buffer layer, said buffer layer disposed between the activated substrate surface layer and the valve metal layer. 33. The surgical implant according to claim 32 , wherein the buffer layer comprises a plurality of alternating layers of a first material and a second material. 34. The surgical implant according to claim 33 , wherein the first material comprises a metal material and the second material comprises a nitride and/or a carbide of the metal material. 35. The surgical implant according to claim 34 , wherein the first material comprises Ti and Cr and the second material comprises a combination independently selected from the group consisting of TiN, CrN, TiC, CrC and mixtures thereof. 36. The surgical implant according to claim 32 , wherein the buffer layer comprises a c
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title
for reconstruction of bones; weight-bearing implants · CPC title
Materials at least partially X-ray or laser opaque · CPC title
Other specific inorganic materials not covered by A61L31/084 or A61L31/086 · CPC title
for reconstruction of the heart, e.g. heart valves · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.